Clinical Trial Update: Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

View source ↗

Summary

This clinical trial update describes the development of a new metabolic imaging approach (aMRI) to evaluate neurological disease in patients with gliomas, and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Glioma | Status: RECRUITING